AKR1B10 expression was detected in nasopharyngeal benign and para-cancerous tissues, adenoids, inflammatory hyperplasia, differentiated nasopharyngeal carcinoma, undifferentiated nasopharyngeal carcinoma, and lymphatic metastases (Fig. 1a-ii). This evidence concerns the gene AKR1B10 and nasopharyngeal carcinoma.